These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32387640)

  • 21. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic susceptibility of Streptococcus pneumoniae isolates from paediatric patients.
    Latorre Otín C; Jumcasa Morros T; Sanfeliu Sala I
    J Antimicrob Chemother; 1988 Nov; 22(5):659-65. PubMed ID: 3209525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The phenotype and genotype patterns of erythromycin-resistant Streptococcus pneumoniae].
    Zhao TM; Liu YN
    Zhonghua Nei Ke Za Zhi; 2004 May; 43(5):329-32. PubMed ID: 15182500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies.
    Davies TA; Kelly LM; Jacobs MR; Appelbaum PC
    J Clin Microbiol; 2000 Apr; 38(4):1444-8. PubMed ID: 10747123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of bioactive extracts from rare actinomycetes against multi-drug resistant Streptococcus pneumoniae.
    Tiwari K; Raj VS; Upadhyay DJ; Gupta RK
    J Appl Microbiol; 2015 Jun; 118(6):1306-14. PubMed ID: 25810118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of quinupristin/dalfopristin against Streptococcus pneumoniae in vitro and in vivo in the rabbit model of experimental meningitis.
    Tarasi A; Dever LL; Tomasz A
    J Antimicrob Chemother; 1997 May; 39 Suppl A():121-7. PubMed ID: 9511076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of telithromycin against erythromycin-susceptible and -resistant Streptococcus pneumoniae isolates from adults with invasive infections.
    Ortega M; Marco F; Almela M; Puig J; Soriano A; Mensa J
    Int J Antimicrob Agents; 2004 Dec; 24(6):616-8. PubMed ID: 15555888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae: in vitro activity and a Galleria mellonella model.
    Yang H; Chen G; Hu L; Liu Y; Cheng J; Ye Y; Li J
    J Microbiol Immunol Infect; 2018 Feb; 51(1):70-75. PubMed ID: 26906264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of
    Zhang W; Guo Y; Yang Y; Dong D; Zheng Y; Zhu D; Hu F
    Microb Drug Resist; 2020 Mar; 26(3):204-210. PubMed ID: 31553260
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibiotic resistance and serotypes of Streptococcus pneumoniae from patients with community-acquired pneumococcal disease.
    Liñares J; Garau J; Domínguez C; Pérez JL
    Antimicrob Agents Chemother; 1983 Apr; 23(4):545-7. PubMed ID: 6859834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability of disc diffusion susceptibility testing of Streptococcus pneumoniae and adjustment of laboratory-specific breakpoints. Finnish Study Group for Antimicrobial Resistance.
    Manninen R; Leinonen M; Huovinen P; Nissinen A
    J Antimicrob Chemother; 1998 Jan; 41(1):19-26. PubMed ID: 9511033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro.
    Lin E; Stanek RJ; Mufson MA
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1151-3. PubMed ID: 12604560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibiotic resistance of Gram-positive cocci isolated in 2008].
    Dorobăţ OM; Bădicuţ I; Tălăpan D; Tenea C; Rafila A
    Bacteriol Virusol Parazitol Epidemiol; 2010; 55(2):83-92. PubMed ID: 21553473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization, antibiotic resistance pattern and capsular types of invasive Streptococcus pneumoniae isolated from clinical samples in Tehran, Iran.
    Beheshti M; Jabalameli F; Feizabadi MM; Hahsemi FB; Beigverdi R; Emaneini M
    BMC Microbiol; 2020 Jun; 20(1):167. PubMed ID: 32546124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Castanheira M; Gales AC; Pignatari AC; Jones RN; Sader HS
    Microb Drug Resist; 2006; 12(2):91-8. PubMed ID: 16922623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial Activity of Peptide-Coupled Antisense Peptide Nucleic Acids in Streptococcus pneumoniae.
    Barkowsky G; Abt C; Pöhner I; Bieda A; Hammerschmidt S; Jacob A; Kreikemeyer B; Patenge N
    Microbiol Spectr; 2022 Dec; 10(6):e0049722. PubMed ID: 36321914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increased resistance of streptococcus pneumoniae to antibiotics and prevalence of their capsular serotypes (author's transl)].
    Goldstein FW; Dang Van A; Bouanchaud DH; Acar JF
    Pathol Biol (Paris); 1978; 26(3-4):173-80. PubMed ID: 28505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of
    Betts JW; Hornsey M; Higgins PG; Lucassen K; Wille J; Salguero FJ; Seifert H; La Ragione RM
    J Med Microbiol; 2019 Oct; 68(10):1552-1559. PubMed ID: 31419210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.